financetom
Business
financetom
/
Business
/
BRIEF-Baupost Opts Out Of IPO For Bill Ackman's Pershing Square Fund- Bloomberg News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Baupost Opts Out Of IPO For Bill Ackman's Pershing Square Fund- Bloomberg News
Jul 29, 2024 2:54 PM

July 29 (Reuters) -

* BAUPOST OPTS OUT OF IPO FOR BILL ACKMAN'S PERSHING SQUARE

FUND-

BLOOMBERG NEWS

Source text: https://tinyurl.com/2xrgkqhq

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Mustang Bio Expects $2.5 Million Gross Proceeds From Registered Direct Offering, Private Placement
Mustang Bio Expects $2.5 Million Gross Proceeds From Registered Direct Offering, Private Placement
Jun 20, 2024
09:20 AM EDT, 06/20/2024 (MT Newswires) -- Mustang Bio ( MBIO ) said Thursday that it expects to raise $2.5 million in gross proceeds through a registered direct offering and concurrent private placement. The company said it has agreed to sell 6.13 million shares in a registered direct offering at $0.41 per share and offer up to an equal number...
Abitibi Metals Reports Final Phase 1 Drilling Results from B26 Deposit in Quebec
Abitibi Metals Reports Final Phase 1 Drilling Results from B26 Deposit in Quebec
Jun 20, 2024
09:19 AM EDT, 06/20/2024 (MT Newswires) -- Abitibi Metals ( AMQFF ) reported Thursday the final results from phase-one drilling at the B26 polymetallic deposit in Quebec. According to a statement, highlights include 9.75 meters at 3.97% copper equivalent, 5.8 meters at 4.43% copper equivalent and 14 meters at 1.16% copper equivalent. We are very excited about the impact of...
GRI Bio Files Shelf for Common Stock Sale
GRI Bio Files Shelf for Common Stock Sale
Jun 20, 2024
09:19 AM EDT, 06/20/2024 (MT Newswires) -- GRI Bio ( GRI ) has filed a preliminary prospectus for an offering of an undisclosed amount of common shares and accompanying warrants to purchase common shares. The company said it plans to use the net proceeds from the offering for product candidate development activities and general corporate purposes. Shares of GRI Bio...
Johnson & Johnson Says Phase 3 Trial of Tremfya to Treat Crohn's Disease Met Co-Primary Endpoints
Johnson & Johnson Says Phase 3 Trial of Tremfya to Treat Crohn's Disease Met Co-Primary Endpoints
Jun 20, 2024
09:20 AM EDT, 06/20/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Thursday the phase 3 trial of Tremfya subcutaneous induction therapy in adults with Crohn's disease reached both co-primary endpoints. The trial achieved statistically significant and clinically meaningful outcomes for clinical remission at week 12 as well as endoscopic response at week 12, the company said. All...
Copyright 2023-2026 - www.financetom.com All Rights Reserved